Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/18/2003WO2003104412A2 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003WO2003104411A2 Bioartificial liver system
12/18/2003WO2003104409A2 Maintenance of islet cells
12/18/2003WO2003104402A2 Non-polymeric hematopoietic cell clots for delivery of active agents
12/18/2003WO2003104393A2 Three dimensional vaginal tissue model containing immune cells
12/18/2003WO2003104385A1 Device for multiple simultaneous gene transfer
12/18/2003WO2003104313A1 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof
12/18/2003WO2003104272A1 Immunogenic compositions
12/18/2003WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF
12/18/2003WO2003103813A2 Materials and reactor systems having humidity and gas control
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103720A2 Compositions and methods for the use of bcl-2 transfected neurons
12/18/2003WO2003103707A1 New method and composition for producing a cellular allogeneic vaccine
12/18/2003WO2003103613A2 Induction of insulin expression
12/18/2003WO2003103611A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
12/18/2003WO2003103607A2 Viral envelope mediated fusion assay
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103581A2 Compositions and methods for liver growth and liver protection
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003103573A2 Methods for treating a neurological disorder by peripheral administration of a trophic factor
12/18/2003WO2003103390A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003WO2003103389A2 Cryopreservation of haptenized tumor cells
12/18/2003WO2003080660A3 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
12/18/2003WO2003078967A3 Stem cell selection and differentiation
12/18/2003WO2003074692A3 Specific gene expression in colonic cancer cell lines
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003066847A3 Phytase variants
12/18/2003WO2003059953A3 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003054160A3 Cell lines with latent immunodeficiency virus and methods of use thereof
12/18/2003WO2003052054A3 Bgl5 beta-glucosidase and nucleic acids encoding the same
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003051907A3 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003046131A3 Dnmt3l-related cloning and reproductive methods
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003040336A3 Stem and progenitor cell capture for tissue regeneration
12/18/2003WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
12/18/2003WO2003031608A3 Mutated abl kinase domains
12/18/2003WO2003029444A3 Method and device for extracting secondary plant constituents
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003027244A3 Antisense oligonucleotides and methods to induce tumor cell death
12/18/2003WO2003026578A3 Pine cone extracts and uses thereof
12/18/2003WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
12/18/2003WO2003025149A3 Cell populations which co-express cd49c and cd90
12/18/2003WO2003024297A3 Cell storage and delivery system
12/18/2003WO2003020896A9 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
12/18/2003WO2003018810A3 Modified cry3a toxins and nucleic acid sequences coding therefor
12/18/2003WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia
12/18/2003WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002099095A3 Improved isoprenoid production
12/18/2003WO2002099035A3 Chimeric alphavirus replicon particles
12/18/2003WO2002097045A3 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/18/2003WO2002090509A3 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
12/18/2003WO2002085305A3 Compositions and methods for inducing cancer cell death
12/18/2003WO2002081668A3 Desaturase genes and uses thereof
12/18/2003WO2002079456B1 A method for the preparation of immunologically inert amniotic membranes
12/18/2003WO2002079388A3 Modulation of mhc class i antigen presentation
12/18/2003WO2002078599A3 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
12/18/2003WO2002074157A3 A mammalian immortalized liver cell
12/18/2003WO2002070660A3 Proteins and nucleic acids encoding same
12/18/2003WO2002064740A3 Cone snail peptides
12/18/2003WO2002057423A3 Isolating cells expressing secreted proteins
12/18/2003WO2002051980A9 In vitro-derived adult pluripotent stem cells and uses therefor
12/18/2003WO2000065025A3 Dna molecules encoding human endothelin converting enzyme 3
12/18/2003US20030233681 ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants
12/18/2003US20030233669 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
12/18/2003US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003US20030232433 The use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leucemia
12/18/2003US20030232432 Culturing mesenchymal stem cells for use in treating cancer, diabetes and nervous system disorders; regenerative medicine
12/18/2003US20030232431 Cellular transplantation for heart regeneration
12/18/2003US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/18/2003US20030232429 System for culturing human cells and tissues
12/18/2003US20030232414 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
12/18/2003US20030232404 Comprises heat resistant beetle luciferase with increased half-life for use as diagnostic tool in genetic engineering
12/18/2003US20030232387 Antibodies that bind alphaE integrin
12/18/2003US20030232377 Based on fetal cells present in peripheral maternal blood; a method for isolating fetal cells from maternal blood
12/18/2003US20030232360 An in vitro system that recapitulates regulated mRNA stability and turnover of exogenous RNA substrates; used to identify agents capable of modulating RNA turnover in the presence of RNA stability modifying agents
12/18/2003US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning
12/18/2003US20030232357 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria
12/18/2003US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232339 Human TRPCC cation channel and uses
12/18/2003US20030232334 Novel compositions and methods for cancer
12/18/2003US20030232058 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/18/2003US20030232050 Compositions and methods for regulating angiogenesis
12/18/2003US20030232041 For use in food and feeds
12/18/2003US20030232036 Alphavirus RNA replicon systems
12/18/2003US20030232035 Capable of expressing a heterologous sequence in target cells; vaccines
12/18/2003US20030232022 P. gingivalis antigenic composition
12/18/2003CA2855445A1 Methods and compositions for production of maize lines with increased transformability
12/18/2003CA2489076A1 Cryopreservation of haptenized tumor cells
12/18/2003CA2488778A1 Assay to detect replication competent viruses
12/18/2003CA2488774A1 Immunomodulation using altered dendritic cells
12/18/2003CA2488744A1 Compositions and methods for the use of bcl-2 transfected neurons